Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Ethical Issues in Behavioral Neuroscience / / edited by Grace Lee, Judy Illes, Frauke Ohl
| Ethical Issues in Behavioral Neuroscience / / edited by Grace Lee, Judy Illes, Frauke Ohl |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2015 |
| Descrizione fisica | 1 online resource (321 p.) |
| Disciplina |
174.2
340 610 610.1 612.8 616.8 617.48 |
| Collana | Current Topics in Behavioral Neurosciences |
| Soggetto topico |
Neurosciences
Bioethics Law Neurology Nervous system - Surgery Neuroscience Neurosurgery |
| ISBN | 3-662-44866-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section I. Experimental Animal Research -- Ethical Issues Associated with the Use of Animal Experimentation in Behavioural Neuroscience Research -- The use of animal models in behavioural neuroscience research -- Does the goal justify the methods? Harm and Benefit in Neuroscience Research Using Animals -- A Framework for investigating animal consciousness -- Telos, Conservation of Welfare, and Ethical Issues in Genetic Engineering of Animals -- Would the elimination of the capacity to suffer evolve ethical dilemmas in experimental animal research? -- Section II. Clinical Research -- Ethics of human research in behavioral neuroscience: Overview of section II -- What’s special about the ethical challenges of studying disorders with altered brain activity? -- Effects of brain injury on moral agency: Ethical dilemmas in investigating human behavior -- Genetic testing and neuroimaging for youth at risk for mental illness: Trading off benefit and risk -- Externalization of consciousness: Scientific possibilities and clinical implications -- How does enhancing cognition affect human values? How does this translate into social responsibility? -- Deep brain stimulation: A principled and pragmatic approach to understanding the ethical and clinical challenges of an evolving technology -- Ethical issues and ethical therapy associated with anxiety disorders -- Just like a circus: The public consumption of sex differences -- Money and morals: Ending clinical trials for financial reasons. |
| Record Nr. | UNINA-9910298293803321 |
| Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Oxford handbook of neuroethics / / edited by Judy Illes [and three others]
| The Oxford handbook of neuroethics / / edited by Judy Illes [and three others] |
| Pubbl/distr/stampa | Oxford, [England] : , : Oxford University Press, , 2011 |
| Descrizione fisica | 1 online resource (xxxix, 935 p.) : ill |
| Disciplina | 174.2968 |
| Collana | Oxford library of psychology |
| Soggetto topico |
Brain - Research - Moral and ethical aspects
Neurosciences - Moral and ethical aspects |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-19-174394-1
0-19-162216-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910457888503321 |
| Oxford, [England] : , : Oxford University Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Oxford handbook of neuroethics [[electronic resource] /] / edited by Judy Illes and Barbara J. Sahakian
| The Oxford handbook of neuroethics [[electronic resource] /] / edited by Judy Illes and Barbara J. Sahakian |
| Pubbl/distr/stampa | Oxford, : Oxford University Press, 2011 |
| Descrizione fisica | 1 online resource (xxxix, 935 p.) : ill |
| Disciplina | 174.2968 |
| Altri autori (Persone) |
IllesJudy
SahakianB. J |
| Collana | Oxford library of psychology |
| Soggetto topico |
Brain - Research - Moral and ethical aspects
Cognitive neuroscience - Moral and ethical aspects |
| ISBN |
0-19-174394-1
0-19-162216-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Neuroethics |
| Record Nr. | UNINA-9910781564003321 |
| Oxford, : Oxford University Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Oxford handbook of neuroethics / / edited by Judy Illes and Barbara J. Sahakian
| The Oxford handbook of neuroethics / / edited by Judy Illes and Barbara J. Sahakian |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Oxford, : Oxford University Press, 2011 |
| Descrizione fisica | 1 online resource (xxxix, 935 p.) : ill |
| Disciplina | 174.2968 |
| Altri autori (Persone) |
IllesJudy
SahakianB. J |
| Collana | Oxford library of psychology |
| Soggetto topico |
Brain - Research - Moral and ethical aspects
Cognitive neuroscience - Moral and ethical aspects |
| ISBN |
0-19-174394-1
0-19-162216-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover Page -- Title Page -- Copyright Page -- FOREWORD BRIDGING NEUROSCIENCE AND SOCIETY: RESEARCH, EDUCATION, AND BROAD PUBLIC ENGAGEMENT -- INTRODUCTION -- A BROAD SOCIETAL CONTEXT -- SOURCES OF SCIENCE-SOCIETY TENSION -- NEUROSCIENCE-SOCIETY TENSION POINTS -- THE DISORDERED MIND: MENTAL ILLNESS AND ADDICTION -- ANTICIPATING NEUROSCIENCE-SOCIETY TENSION -- THE PUBLIC ENGAGEMENT APPROACH -- PRINCIPLES OF PUBLIC ENGAGEMENT -- CONCLUDING COMMENTS -- REFERENCES -- PREFACE -- ACKNOWLEDGMENTS -- CONTENTS -- NOTES ON THE CONTRIBUTORS -- LIST OF ABBREVIATIONS -- PART I CONSCIOUSNESS AND INTENTION: DECODING MENTAL STATES AND DECISION MAKING -- CHAPTER 1 BRAIN READING: DECODING MENTAL STATES FROM BRAIN ACTIVITY IN HUMANS -- CHAPTER 2 THE NEUROBIOLOGY OF PLEASURE AND HAPPINESS -- CHAPTER 3 THE NEUROBIOLOGICAL BASIS OF MORALITY -- CHAPTER 4 DEVELOPMENT OF THE ADOLESCENT BRAIN: NEUROETHICAL IMPLICATIONS FOR THE UNDERSTANDING OF EXECUTIVE FUNCTION AND SOCIAL COGNITION -- CHAPTER 5 NEURAL FOUNDATIONS TO CONSCIOUS AND VOLITIONAL CONTROL OF EMOTIONAL BEHAVIOR: A MENTALISTIC PERSPECTIVE -- CHAPTER 6 NEURAL CORRELATES OF DECEPTION -- CHAPTER 7 UNDERSTANDING DISORDERS OF CONSCIOUSNESS -- CHAPTER 8 FUNCTIONAL MAGNETIC RESONANCE IMAGING, COVERT AWARENESS, AND BRAIN INJURY -- PART II RESPONSIBILITY AND DETERMINISM -- CHAPTER 9 GENETIC DETERMINISM, NEURONAL DETERMINISM, AND DETERMINISM TOUT COURT -- CHAPTER 10 THE RISE OF NEUROESSENTIALISM -- CHAPTER 11 A NEUROSCIENTIFIC APPROACH TO ADDICTION: ETHICAL CONCERNS -- CHAPTER 12 THE NEUROBIOLOGY OF ADDICTION: IMPLICATIONS FOR VOLUNTARY CONTROL OF BEHAVIOR -- CHAPTER 13 NEUROETHICS OF FREE WILL -- PART III MIND AND BODY -- CHAPTER 14 PHARMACEUTICAL COGNITIVE ENHANCEMENT -- CHAPTER 15 COGNITIVE ENHANCEMENT.
CHAPTER 16 CHEMICAL COGNITIVE ENHANCEMENT: IS IT UNFAIR, UNJUST, DISCRIMINATORY, OR CHEATING FOR HEALTHY ADULTS TO USE SMART DRUGS? -- CHAPTER 17 COGNITIVE ENHANCEMENT IN COURTS -- CHAPTER 18 NEUROETHICS AND THE EXTENDED MIND -- CHAPTER 19 DOES COGNITIVE ENHANCEMENT FIT WITH THE PHYSIOLOGY OF OUR COGNITION? -- CHAPTER 20 ATTENTION DEFICIT HYPERACTIVITY DISORDER: DEFINING A SPECTRUM DISORDER AND CONSIDERING NEUROETHICAL IMPLICATIONS -- PART IV NEURO-TECHNOLOGY -- CHAPTER 21 WHY NEUROETHICISTS ARE NEEDED -- CHAPTER 22 INTERSECTING COMPLEXITIES IN NEUROIMAGING AND NEUROETHICS -- CHAPTER 23 PEDIATRIC NEUROIMAGING RESEARCH -- CHAPTER 24 ETHICAL ISSUES IN FUNCTIONAL NEUROSURGERY: EMERGING APPLICATIONS AND CONTROVERSIES -- CHAPTER 25 NON-INVASIVE BRAIN STIMULATION AS A THERAPEUTIC AND INVESTIGATIVE TOOL: AN ETHICAL APPRAISAL -- CHAPTER 26 DEEP BRAIN STIMULATION FOR TREATMENT-RESISTANT NEUROPSYCHIATRIC DISORDERS -- CHAPTER 27 THE ETHICAL ISSUES OF TRIALS OF NEURAL GRAFTING IN PATIENTS WITH NEURODEGENERATIVE CONDITIONS -- CHAPTER 28 THE ETHICS OF NANO/NEURO CONVERGENCE -- PART V AGING AND DEMENTIA -- CHAPTER 29 NEUROBIOLOGICAL AND NEUROETHICAL PERSPECTIVES ON THE CONTRIBUTION OF FUNCTIONAL NEUROIMAGING TO THE STUDY OF AGING IN THE BRAIN -- CHAPTER 30 CLINICAL RESEARCH ON CONDITIONS AFFECTING COGNITIVE CAPACITY -- CHAPTER 31 ETHICAL CONCERNS AND PITFALLS IN NEUROGENETIC TESTING -- CHAPTER 32 NEUROETHICAL ISSUES IN EARLY DETECTION OF ALZHEIMER'S DISEASE -- CHAPTER 33 THE NEUROETHICS OF COGNITIVE RESERVE -- CHAPTER 34 ETHICAL ISSUES IN THE MANAGEMENT OF PARKINSON'S DISEASE -- CHAPTER 35 THE OTHER ETHICAL CHALLENGE OF NEURODEGENERATIVE DISEASES -- CHAPTER 36 FUTURE SCOPING: ETHICAL ISSUES IN AGING AND DEMENTIA -- PART VI LAW AND PUBLIC POLICY. CHAPTER 37 INCIDENTAL FINDINGS IN NEUROSCIENCE RESEARCH: A FUNDAMENTAL CHALLENGE TO THE STRUCTURE OF BIOETHICS AND HEALTH LAW -- CHAPTER 38 WHAT WILL BE THE LIMITS OF NEUROSCIENCE-BASED MINDREADING IN THE LAW? -- CHAPTER 39 FOR THE LAW, NEUROSCIENCE CHANGES NOTHING AND EVERYTHING -- CHAPTER 40 NEW DIRECTIONS IN NEUROSCIENCE POLICY -- CHAPTER 41 WOMEN'S NEUROETHICS -- CHAPTER 42 PUBLIC REPRESENTATIONS OF NEUROGENETICS -- CHAPTER 43 BRAIN TRUST: NEUROSCIENCE AND NATIONAL SECURITY IN THE 21ST CENTURY -- PART VII SCIENCE, SOCIETY, AND INTERNATIONAL PERSPECTIVES -- CHAPTER 44 NEUROPLASTICITY, CULTURE, AND SOCIETY -- CHAPTER 45 NEUROSCIENCE AND NEUROETHICS IN THE 21ST CENTURY -- CHAPTER 46 NEUROSCIENCE AND THE MEDIA: ETHICAL CHALLENGES AND OPPORTUNITIES -- CHAPTER 47 ETHICAL ISSUES IN EDUCATIONAL NEUROSCIENCE: RAISING CHILDREN IN A BRAVE NEW WORLD -- CHAPTER 48 FROM THE INTERNATIONALIZATION TO THE GLOBALIZATION OF NEUROETHICS: SOME PERSPECTIVES AND CHALLENGES -- CHAPTER 49 GLOBAL HEALTH ETHICS -- CHAPTER 50 ETHICAL PERSPECTIVES: CLINICAL DRUG TRIALS IN DEVELOPING COUNTRIES -- CHAPTER 51 LEARNING ABOUT NEUROETHICS THROUGH HEALTH SCIENCES ONLINE: A MODEL FOR GLOBAL DISSEMINATION -- EPILOGUE -- CHAPTER 52 NEUROETHICS AND THE LURE OF TECHNOLOGY -- SUBJECT INDEX -- AUTHOR INDEX -- PLATES -- Footnote -- Ch17_Fn-01 -- Ch17_Fn-02 -- Ch19_Fn-01 -- Ch19_Fn-02 -- Ch19_Fn-03 -- Ch19_Fn-04 -- Ch39_Fn-01 -- Ch39_Fn-02 -- Ch39_Fn-03 -- Ch39_Fn-04 -- Ch39_Fn-05 -- Ch39_Fn-06 -- Ch40_Fn-01 -- Ch40_Fn-02 -- Ch43_Fn-01 -- Ch43_Fn-02 -- Ch47_Fn-01 -- Ch47_Fn-02 -- Ch47_Fn-03 -- Ch47_Fn-04. |
| Altri titoli varianti | Neuroethics |
| Record Nr. | UNINA-9910816804903321 |
| Oxford, : Oxford University Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The science and ethics of antipsychotic use in children / / edited by Nina Di Pietro and Judy Illes ; contributors, Mai Berger [and twenty others]
| The science and ethics of antipsychotic use in children / / edited by Nina Di Pietro and Judy Illes ; contributors, Mai Berger [and twenty others] |
| Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (228 p.) |
| Disciplina | 615.7882 |
| Soggetto topico |
Antipsychotic drugs
Children - Drug use |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; The Science and Ethics of Antipsychotic Use in Children; Copyright; Contents; Contributors; Foreword; Acknowledgments; Introduction: A Call for Partnership; References; Chapter 1: A Brief History of the Science and Ethics of Antipsychotics and Off-Label Prescribing; A New Era in Psychopharmacology Research Begins; A Second Generation Emerges; The Expansion of Antipsychotics: Off-Label Use in Children; Benefits in the Face of Risks; A Call for Partnership; References; Chapter 2: Pharmacoepidemiology of Antipsychotic Use in Canadian Children and Adolescents; Introduction
Differences in SGA Regulation Between Canada and Other CountriesCanadian Second-Generation Antipsychotic Medications Prescription Trends for Children and Adolescents; National Prescribing Trends; Provincial Prescribing Trends; Manitoba; Nova Scotia; British Columbia; Comparing Canadian SGA Prescription Trends to those in Other Countries; Conclusions; References; Chapter 3: Do We Know If They Work and If They Are Safe: Second-Generation Antipsychotics for Treatment of Autism Spectrum ...; Introduction; Methods; Efficacy of SGAs for Children and Adolescents With ASDs Efficacy of SGAs for Children and Adolescents With DBDsSummary of Adverse Effects and Safety Data from ASD and DBD Trials Combined; Discussion; SGAs Included in RCTs; Efficacy in ASD Trials; Efficacy in DBD trials; Critique and Ethical Considerations; Conclusion; References; ASD Studies: Aripiprazole; ASD Studies: Olanzapine; ASD Studies: Risperidone; DBD Studies: Aripiprazole; DBD Studies: Quetiapine; DBD Studies: Risperidone; Chapter 4: Ensuring the Safety of Children Treated with Second-Generation Antipsychotics; Introduction; Side Effects associated with SGA use in Children and Youth Monitoring the Health of Children and Youth on SGAsGuidelines for Metabolic Monitoring; Recommendations for Monitoring Metabolic Changes; Height; Weight; Body Mass Index; Waist Circumference; Blood Pressure; Management of Metabolic Complications; Why Standardized Metabolic Monitoring Matters; Improving Patient Care; Educating Families; Overcoming Barriers to Completion of Monitoring; Conclusion; References; Chapter 5: Pediatric Clinical Trial Activity for Antipsychotics and the Sharing of Results: A Complex Ethical Landscape; Introduction; Patient Safety, Ethics, and Clinical Trial Regulation The Push for Pediatric Clinical TrialsThe Push for Clinical Trial Registration; Reporting of Results; Mapping the Landscape: Clinical Trials for Antipsychotics in Children and Youth; Methods; Results; Reflections On The Current State Of Pediatric Clinical Trials For Antipsychotics; The Landscape of Clinical Trial Activity; Developmental Gaps; The Strength of Evidence; Uniformity in Outcome Measures; Gaps in Results Reporting; Recruitment and Willingness to Participate in Research; Informed Consent; Limitations; Recommendations; References Chapter 6: Pathways to Overmedication and Polypharmacy: Case Examples from Adolescents with Fetal Alcohol Spectrum Disorders |
| Record Nr. | UNINA-9910788115303321 |
| Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The science and ethics of antipsychotic use in children / / edited by Nina Di Pietro and Judy Illes ; contributors, Mai Berger [and twenty others]
| The science and ethics of antipsychotic use in children / / edited by Nina Di Pietro and Judy Illes ; contributors, Mai Berger [and twenty others] |
| Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (228 p.) |
| Disciplina | 615.7882 |
| Soggetto topico |
Antipsychotic drugs
Children - Drug use |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; The Science and Ethics of Antipsychotic Use in Children; Copyright; Contents; Contributors; Foreword; Acknowledgments; Introduction: A Call for Partnership; References; Chapter 1: A Brief History of the Science and Ethics of Antipsychotics and Off-Label Prescribing; A New Era in Psychopharmacology Research Begins; A Second Generation Emerges; The Expansion of Antipsychotics: Off-Label Use in Children; Benefits in the Face of Risks; A Call for Partnership; References; Chapter 2: Pharmacoepidemiology of Antipsychotic Use in Canadian Children and Adolescents; Introduction
Differences in SGA Regulation Between Canada and Other CountriesCanadian Second-Generation Antipsychotic Medications Prescription Trends for Children and Adolescents; National Prescribing Trends; Provincial Prescribing Trends; Manitoba; Nova Scotia; British Columbia; Comparing Canadian SGA Prescription Trends to those in Other Countries; Conclusions; References; Chapter 3: Do We Know If They Work and If They Are Safe: Second-Generation Antipsychotics for Treatment of Autism Spectrum ...; Introduction; Methods; Efficacy of SGAs for Children and Adolescents With ASDs Efficacy of SGAs for Children and Adolescents With DBDsSummary of Adverse Effects and Safety Data from ASD and DBD Trials Combined; Discussion; SGAs Included in RCTs; Efficacy in ASD Trials; Efficacy in DBD trials; Critique and Ethical Considerations; Conclusion; References; ASD Studies: Aripiprazole; ASD Studies: Olanzapine; ASD Studies: Risperidone; DBD Studies: Aripiprazole; DBD Studies: Quetiapine; DBD Studies: Risperidone; Chapter 4: Ensuring the Safety of Children Treated with Second-Generation Antipsychotics; Introduction; Side Effects associated with SGA use in Children and Youth Monitoring the Health of Children and Youth on SGAsGuidelines for Metabolic Monitoring; Recommendations for Monitoring Metabolic Changes; Height; Weight; Body Mass Index; Waist Circumference; Blood Pressure; Management of Metabolic Complications; Why Standardized Metabolic Monitoring Matters; Improving Patient Care; Educating Families; Overcoming Barriers to Completion of Monitoring; Conclusion; References; Chapter 5: Pediatric Clinical Trial Activity for Antipsychotics and the Sharing of Results: A Complex Ethical Landscape; Introduction; Patient Safety, Ethics, and Clinical Trial Regulation The Push for Pediatric Clinical TrialsThe Push for Clinical Trial Registration; Reporting of Results; Mapping the Landscape: Clinical Trials for Antipsychotics in Children and Youth; Methods; Results; Reflections On The Current State Of Pediatric Clinical Trials For Antipsychotics; The Landscape of Clinical Trial Activity; Developmental Gaps; The Strength of Evidence; Uniformity in Outcome Measures; Gaps in Results Reporting; Recruitment and Willingness to Participate in Research; Informed Consent; Limitations; Recommendations; References Chapter 6: Pathways to Overmedication and Polypharmacy: Case Examples from Adolescents with Fetal Alcohol Spectrum Disorders |
| Record Nr. | UNINA-9910819137803321 |
| Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||